Gene · 715
Papers2,917
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,917
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multi-omics analyses demonstrate complement dysregulation is involved in focal segmental glomerulosclerosis. | Front Immunol | 2026 | 42780117 | PubTator, text mining | PubMed |
| Complement expression profiles in human glomerular mesangial cells, endothelial cells, podocytes and proximal tubular epithelial cells. | Front Immunol | 2026 | 42746023 | PubTator, text mining | PubMed |
| Shared dysregulation of complement and phosphorylation pathways in the cerebrospinal fluid of encephalitis, Aicardi-Goutières syndrome, and autism. | Dev Med Child Neurol | 2026 | 42615359 | PubTator, text mining | PubMed |
| Plasma Proteomic Signatures in Alkaptonuria. | Biology (Basel) | 2026 | 42589138 | PubTator, text mining | PubMed |
| C1R suppresses hepatocellular carcinoma cell aggressiveness through promoting HIF-1α degradation and modulating cuproptosis-related protein expression. | Int Immunopharmacol | 2026 | 42561667 | PubTator, text mining | PubMed |
| Plasma Extracellular Vesicles-Derived Complement Proteins as Biomarkers of Sarcopenia Progression in Longitudinal Cohorts. | J Cachexia Sarcopenia Muscle | 2026 | 42477892 | PubTator, text mining | PubMed |
| Complement dysregulation during the early phases of synucleinopathy. | Acta Neuropathol | 2026 | 42477211 | PubTator, text mining | PubMed |
| Common and rare variants in complement genes as biomarkers of COVID-19 infection and severity. A lesson to learn for emerging pathogens. | Front Immunol | 2026 | 42367796 | PubTator, text mining | PubMed |
| Serum complement system activation in normal healing and atrophic non-union of human long bone fractures. | Front Immunol | 2026 | 42344890 | PubTator, text mining | PubMed |
| Modulation of NF-κB and TLR Signaling Pathways and Complement Components in Ovine Maternal Thyroid During Early Pregnancy. | Int J Mol Sci | 2026 | 42278321 | PubTator, text mining | PubMed |
| Genetic landscape of early-onset systemic lupus erythematous in India. | Rheumatology (Oxford) | 2026 | 42251732 | PubTator, text mining | PubMed |
| Production and characterization of gigastasin, a leech-derived inhibitor of complement and coagulation pathways. | Sci Rep | 2026 | 42143157 | PubTator, text mining | PubMed |
| Complement Dysregulation During the Early Phases of Synucleinopathy. | bioRxiv | 2026 | 42094452 | PubTator, text mining | PubMed |
| Complement Components C1r and C8 Serve as Potential Inflammatory Biomarkers for Coronary Heart Disease Severity: The Mediating Role of C-Reactive Protein. | J Inflamm Res | 2026 | 42064727 | PubTator, text mining | PubMed |
| Tumour cell-intrinsic complement C1r and C1s regulate cancer cell fitness and shape the immune microenvironment in triple-negative breast cancer. | Cell Mol Life Sci | 2026 | 42018193 | PubTator, text mining | PubMed |
| Conditionally Reprogrammed Cells Preserve Cellular Diversity and Permit Genetic Manipulation: Implications for Cancer Heterogeneity and Tissue Regeneration. | Serican J Med | 2026 | 41972234 | PubTator, text mining | PubMed |
| Phenotypic periodontal Ehlers-Danlos syndrome without C1R/C1S variants: a case supporting genetic heterogeneity. | Med Clin (Barc) | 2026 | 41936790 | PubTator, text mining | PubMed |
| Serum-Inert Tandem-Locked Fluorescent Probe for Specific Imaging of Intratumoral Complement System. | Adv Mater | 2026 | 41891683 | PubTator, text mining | PubMed |
| Comprehensive single-cell metabolic profiling identifies targets to sensitize triple-negative breast cancer to chemo-immunotherapy. | Cell Rep Med | 2026 | 41850242 | PubTator, text mining | PubMed |
| Identification of tofersen PD-response biomarkers in VALOR clinical trial CSF via multiplexed quantitative proteomics. | Cell Rep Med | 2026 | 41850233 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/715/papers